Clinical Trials in North Carolina

Showing 4741-4760 of 14,780 trials

Genetic Architecture of Avoidant/Restrictive Food Intake Disorder

NCT05605067

The goal of this observational study is to rapidly accelerate knowledge about the biology of avoidant and restrictive food intake disorder or ARFID in children ages 7-17 and in adults. The investigators will be evaluating the genetic and environmental origins of ARFID. Participants will be asked to answer questionnaires online and to submit a saliva sample for DNA using a kit that will be mailed to their home.

ARFIDEating DisordersEating Disorders in Children+1 more

University of North Carolina, Chapel Hill5,076 participantsStarted Jan 2023

Chapel Hill, North Carolina, United States

COMPLETEDNA46 miles

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)

NCT04533711

The purpose of this study is to test an osteoarthritis (OA) primary care Physical activity Care Pathway (OA-PCP), a scalable intervention that includes: 1) a practical process for physical inactivity screening in primary care, 2) a brief, tailored physical activity (PA) counseling intervention via telephone, 3) connection of patients with community programs and other resources to support PA, and 4) follow-up with patients to deliver additional appropriate counseling and referrals to PA resources. This program will be compared to another program that provides education on a variety of topics important to understanding osteoarthritis (OA) and its care.

Osteoarthritis

University of North Carolina, Chapel Hill240 participantsStarted Nov 2020

Chapel Hill, North Carolina, United States

Genetic Architecture of Avoidant/Restrictive Food Intake Disorder

Physical Activity Pathway for Patients With Osteoarthritis in Primary Care (OA-PCP) (R33)

Find Trials by Condition in North Carolina

A Study to Evaluate a Therapeutic Vaccine, ASP0113, in Cytomegalovirus (CMV)-Seropositive Recipients Undergoing Allogeneic, Hematopoietic Cell Transplant (HCT)

Trial Comparing Peripheral I.V. Catheter Complication Rates of Two Different Catheter Dressings

Embo Registry; National Registry for Artery Embolization

Study of BGB-290 or Placebo in Participants With Advanced or Inoperable Gastric Cancer

Utility of Donor-Derived Cell Free DNA in Association With Gene Expression Profiling

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

A Study of LY3473329 in Participants With Impaired and Normal Renal Function

Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants

An Extension Study to Assess Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-4)

Venetoclax and Selinexor in Treating Patients with Relapsed or Refractory High Risk Hematologic Malignancies

ABC008 in Subjects with T-cell Large Granular Lymphocytic Leukemia (T-LGLL)

The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation

A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

A Study of LY3022855 In Participants With Breast or Prostate Cancer

Study of Novel Regimens in Relapsed or Refractory Multiple Myeloma

A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma

Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms